A novel small binding protein that targets PCSK9

3' education - Oct. 6, 2020 - Prof. Evan Stein, MD, PhD - Cincinnati, OH, USA

Educational information

This video was recorded during the virtual 2020 EAS Congress.

Faculty

Prof. Evan Stein, LIB Therapeutics and Metabolic & Atherosclerosis Research Center, Cincinnati, OH, USA.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the recombinant fusion protein

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.